Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Mozes

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Surgery|November 1, 1972
Comparative analysis of perfusion and nonperfusion methods for renal preservationE A Santiago-Delpin, A W Moberg, M F Mozes, et al.
Transplantation Proceedings|February 1, 1995
Clinical and renal histologic predictors of long-term outcome after OKT3 therapy for steroid-resistant rejectionY Wiener, R E Nakhleh, W L Kupin, et al.
Transplantation Proceedings|February 1, 1993
Is the routine use of induction immunosuppression with ALG or OKT3 justified in cadaveric renal transplantation?M F Mozes, K K Venkat, W Kupin, et al.
The New England Journal of Medicine|April 26, 1990
Prevention of acute graft rejection by the prostaglandin E1 analogue misoprostol in renal-transplant recipients treated with cyclosporine and prednisoneM Moran, M F Mozes, M S Maddux, et al.
Clinical Transplantation|June 1, 1997
Prognostic factors and early resumption of cyclosporin A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndromeY Wiener, R E Nakhleh, M W Lee, et al.
Surgical Forum|January 1, 1971
Specificity of the heteroantibody in xenograft rejectionM F Mozes, A R Shons, N S Harris, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1992
A trial of the prostaglandin E1 analogue, enisoprost, to reverse chronic cyclosporine-associated renal dysfunctionR Pollak, R Knight, M F Mozes, et al.
Archives of Surgery (Chicago, Ill. : 1960)|December 1, 1974
Hypothermic pulsatile kidney preservation. Comparative analysis of plasma fractionsL H Toledo-Pereyra, R M Condie, C O Callender, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Surgery|November 1, 1972
Comparative analysis of perfusion and nonperfusion methods for renal preservationE A Santiago-Delpin, A W Moberg, M F Mozes, et al.
Transplantation Proceedings|February 1, 1995
Clinical and renal histologic predictors of long-term outcome after OKT3 therapy for steroid-resistant rejectionY Wiener, R E Nakhleh, W L Kupin, et al.
Transplantation Proceedings|February 1, 1993
Is the routine use of induction immunosuppression with ALG or OKT3 justified in cadaveric renal transplantation?M F Mozes, K K Venkat, W Kupin, et al.
The New England Journal of Medicine|April 26, 1990
Prevention of acute graft rejection by the prostaglandin E1 analogue misoprostol in renal-transplant recipients treated with cyclosporine and prednisoneM Moran, M F Mozes, M S Maddux, et al.
Clinical Transplantation|June 1, 1997
Prognostic factors and early resumption of cyclosporin A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndromeY Wiener, R E Nakhleh, M W Lee, et al.
Surgical Forum|January 1, 1971
Specificity of the heteroantibody in xenograft rejectionM F Mozes, A R Shons, N S Harris, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1992
A trial of the prostaglandin E1 analogue, enisoprost, to reverse chronic cyclosporine-associated renal dysfunctionR Pollak, R Knight, M F Mozes, et al.
Archives of Surgery (Chicago, Ill. : 1960)|December 1, 1974
Hypothermic pulsatile kidney preservation. Comparative analysis of plasma fractionsL H Toledo-Pereyra, R M Condie, C O Callender, et al.
Pageof 7